Video

Certara Phoenix 平台 — 全球最值得信赖的药代动力学/药效学（PK/PD）分析与建模平台

Today’s drug candidates are more complex than ever. But with development decisions on the line,…

Certara2025 年 2 月 12 日

Publication

针对复发难治性（R/R）骨髓纤维化（MF）及其他髓系或实体瘤恶性肿瘤患者的 Navtemadlin 群体药代动力学与药效学分析

This study conducted a population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of navtemadlin, an MDM2…

Certara2025 年 2 月 6 日

Press Coverage

2025 cell and gene challenges: Scalability, supply chain and manufacturing

Explore insights on 2025 challenges in cell and gene therapy, including commercial viability, with expert…

Certara2025 年 2 月 3 日

新闻报导

How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead?

Discover how advances in personalized medicine are reshaping patient care, and why biosimulation will become…

Certara2025 年 1 月 31 日

On-Demand Webinar

转变视角：药物相互作用 PBPK 建模 25 年

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 Vice President and Head of Global PK/PD and Pharmacometrics at Eli Lilly and Company…

Certara2025 年 1 月 29 日